Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Luke

Showing results (41-50 of 422) with videos related to

Pageof 43
Sort By:
NEJM Evidence|February 6, 2024
Progression/Recurrence-Free Survival 2 in Adjuvant MelanomaRyan C Augustin, Jason J Luke
Current Oncology Reports|May 24, 2024
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma TherapyAndrew D Knight, Jason J Luke
Genome Medicine|October 27, 2020
Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer typesRiyue Bao, Daniel Stapor, Jason J Luke
Journal of Dairy Science|March 27, 2010
Siderophore production and utilization by milk spoilage Pseudomonas speciesA G Brown, R K J Luke
Current Oncology Reports|August 3, 2021
Next-Generation Immunotherapy Approaches in MelanomaTyler Buchanan, Afsaneh Amouzegar, Jason J Luke
Journal of Interpersonal Violence|June 26, 2026
Configuration, Not Content: A Network Analysis of Gendered Prototypes of Intimate Partner ViolenceHanna Feige, Timothy J Luke, Karl Ask
Oncotargets and Therapy|October 29, 2020
Toll-Like Receptor 9 Agonists in CancerLilit Karapetyan, Jason J Luke, Diwakar Davar
Peerj|August 23, 2016
Lateral presentation of faces alters overall viewing strategyChristopher J Luke, Petra M J Pollux
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 4, 2019
The Impact of the Fecal Microbiome on Cancer ImmunotherapyAfaf E G Osman, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2024
Unraveling the Therapeutic Benefit of Sequenced Chemo-immunotherapyPaolo D A Vignali, Jason J Luke
Pageof 43

Showing results (41-50 of 422) with videos related to

Sort By:
Pageof 43
NEJM Evidence|February 6, 2024
Progression/Recurrence-Free Survival 2 in Adjuvant MelanomaRyan C Augustin, Jason J Luke
Current Oncology Reports|May 24, 2024
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma TherapyAndrew D Knight, Jason J Luke
Genome Medicine|October 27, 2020
Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer typesRiyue Bao, Daniel Stapor, Jason J Luke
Journal of Dairy Science|March 27, 2010
Siderophore production and utilization by milk spoilage Pseudomonas speciesA G Brown, R K J Luke
Current Oncology Reports|August 3, 2021
Next-Generation Immunotherapy Approaches in MelanomaTyler Buchanan, Afsaneh Amouzegar, Jason J Luke
Journal of Interpersonal Violence|June 26, 2026
Configuration, Not Content: A Network Analysis of Gendered Prototypes of Intimate Partner ViolenceHanna Feige, Timothy J Luke, Karl Ask
Oncotargets and Therapy|October 29, 2020
Toll-Like Receptor 9 Agonists in CancerLilit Karapetyan, Jason J Luke, Diwakar Davar
Peerj|August 23, 2016
Lateral presentation of faces alters overall viewing strategyChristopher J Luke, Petra M J Pollux
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 4, 2019
The Impact of the Fecal Microbiome on Cancer ImmunotherapyAfaf E G Osman, Jason J Luke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2024
Unraveling the Therapeutic Benefit of Sequenced Chemo-immunotherapyPaolo D A Vignali, Jason J Luke
Pageof 43